Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2400082924Phase 3Recruiting
Phase 3, randomised trial of ciprofol (2 arms), sponsored by Fuyang Second People's Hospital. Primary endpoints: Modified Observer's Assessment of Alertness/Sedation (MOAA/S), Bispectral index and 8 more. Started May 2024; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2400082924.